Dosage and administration
apply to affected areas one to 4 times daily or as directed by a doctor use before going to bed for 4 weeks apply 4 doses on scalp section by section (1 dose = 1 pipette) do not rinse
Drug Facts
- Manufacturer
- L'Oreal USA Products Inc. | Interspray
- Effective date
- 2024-12-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 00:50:12
Label at a glance#
ProductKerastase Paris K Symbiose Serum Nuit Antipelliculaire Intensif Antidandruff Treatment
Active ingredientSALICYLIC ACID
Label structure10 sections
Label contents#
Full prescribing information#
Active ingredient
Salicylic acid 1.8%
Purpose
Antidandruff
Use
- helps eliminate the symptoms of dandruff
Warnings
For external use only
When using this product
avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor if
condition worsens or does not improve after regular use of this product as directed
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- apply to affected areas one to 4 times daily or as directed by a doctor
- use before going to bed for 4 weeks
- apply 4 doses on scalp section by section (1 dose = 1 pipette)
- do not rinse
Inactive ingredients
water, alcohol denat., aminomethyl propanol, fragrance, PEG-40 hydrogenated castor oil, bifida ferment lysate, limonene, glycerin, benzyl salicylate, benzyl alcohol, linalool, citronellol, citral, geraniol, artemisia umbelliformis flower extract, coumarin, phenoxyethanol, sodium benzoate, citric acid, potassium sorbate
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49967-363-01 | Kerastase Paris K Symbiose Serum Nuit Antipelliculaire Intensif Antidandruff Treatment | 90 mL in 1 BOTTLE | LIQUID | 90 | 5 | |
| 49967-363-01 | Kerastase Paris K Symbiose Serum Nuit Antipelliculaire Intensif Antidandruff Treatment | 1 in 1 CARTON | LIQUID | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49967-363 | KERASTASE PARIS K SYMBIOSE SERUM NUIT ANTIPELLICULAIRE INTENSIF ANTIDANDRUFF TREATMENT (SALICYLIC ACID) LIQUID [L'OREAL USA PRODUCTS INC.] | 5 | Current NDC, 2 package rows | 20250101_d72688ed-d153-4eed-988f-5386eb68559d.zip |
Products#
Every source-derived product name is available through these pages.
- Kerastase Paris K Symbiose Serum Nuit Antipelliculaire Intensif Antidandruff Treatment
- Salicylic Acid
- WATER
- ALCOHOL
- AMINOMETHYLPROPANOL
- POLYOXYL 40 HYDROGENATED CASTOR OIL
- LIMONENE, (+)-
- GLYCERIN
- BENZYL SALICYLATE
- BENZYL ALCOHOL
- LINALOOL, (+/-)-
- .BETA.-CITRONELLOL, (R)-
- CITRAL
- GERANIOL
- ARTEMISIA UMBELLIFORMIS FLOWER
- COUMARIN
- PHENOXYETHANOL
- SODIUM BENZOATE
- CITRIC ACID MONOHYDRATE
- POTASSIUM SORBATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49967-363 | 49967-363-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kerastase Paris K Symbiose Serum Nuit Antipelliculaire Intensif Antidandruff Treatment | SALICYLIC ACID | L'Oreal USA Products Inc. | d72688ed-d153-4eed-988f-5386eb68559d | 2024-12-30 | Warnings | 49967-363-01 49967-363 49967036301 89fa668f-d2de-4e44-abb7-041277fdc741 d72688ed-d153-4eed-988f-5386eb68559d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.